key: cord-0828604-6dqpe1ci
authors: Alfishawy, Mostafa; Elbendary, Amira; Younes, Abdelrahman; Negm, Ahmed; Hassan, Walid Shehata; Osman, Safinaz Hassan; Nassar, Mahmoud; Elanany, Mervat G.
title: Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt
date: 2021-07-08
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2021.102195
sha: fcbd9b751dcdd697ffd472e62e4e1692edbfd4c7
doc_id: 828604
cord_uid: 6dqpe1ci

nan

To the editor, 1 While the whole world started Coronavirus Disease 2019 (COVID-19) 2 vaccine campaign aiming at ending the pandemic other areas of the world 3 started to suffer from a devastating new complication of the disease. Increased 4 cases of COVID-19 Associated Mucormycosis (CAM) has been noted [1 -3] . 5 We had observed this phenomenon in Egypt over the past few weeks similar to 6 the situation in India. 7 All patients who had imaging findings of bone destruction and suspicion for 8 fungal sinusitis following documented COVID-19 evaluated by authors from 9 March 15 th to May 15 th 2021, were included. The patients' demographic data, 10 comorbidities, host risk factors, microbiologic data and management were 11 collected. 12 The study included 21 patients evaluated in 11 different hospitals in 13 metropolitan Cairo, Egypt (Patient characteristics in Table 1 received itraconazole, and 2 (9.5%) received voriconazole. Mortality was 7/21 20 (33.3%), 5 of them (71.4%) had rhino-cerebral disease.

The aim of this study was to highlight the growing problem of CAM in Egypt 

/14 (100%) corticosteroid intake

2%) Morbid obesity Site 5/14 (35.7%) Sinus 8/14 (57.14%) Rhino-orbital 1/14 (7.14%) Pulmonary 2/7 (28.6%) Rhino-orbital 5/7 (71.4%) Rhino-cerebral